Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Direct Oral Anticoagulants Versus Warfarin in Patients With Non-high-risk Antiphospholipid Syndrome : Prospective Cohort Study

NCT06884384 is registered in ClinicalTrials.gov with Central Hospital, Nancy, France as lead sponsor.

NCT NCT06884384
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06884384 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Direct Oral Anticoagulants Versus Warfarin in Patients With Non-high-risk Antiphospholipid Syndrome : Prospective Cohort Study
Lead sponsor
Central Hospital, Nancy, France
Phase
Observational
Overall status
Not yet recruiting
Start date
September 15, 2025
Completion date
September 15, 2031
Enrollment
310 (estimated)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

antiphospholipid syndrome (aps), cohort study, thrombotic and bleeding events